前立腺の解燐酵素に関する研究 (1)ヒト前立腺フォスフォモノエステラーゼの精製とその免疫学的所見
スポンサーリンク
概要
- 論文の詳細を見る
Prostatic phosphomonoesterase (prostatic PMEase) was purified by London's and Ostrowski's methods as follows. The first step is fullers' earth adsorption, the second step is fractionation with ammonium sulfate, the third step is DEAE cellulose column chromatography and the fourth step is rechromatography of a fraction obtained by the third step. The purified prostatic PMEase was in homogeneous form electrophoretically and ultracentrifugally. Four distinct peaks of protein were obtained by the DEAE cellulose column chromatography and the PMEase activity was exhibited in the three peaks except the first peak. Each peak of the purified materials by the DEAE cellulose column chromatography was examined by immunoelectrophoresis with antihuman prostatic PMEase serum of the rabbit. The PMEase of peak II migrates to the cathode, that of peak III migrates slightly to the anode and that of peak IV migrates to the anode more than that of peak III. It was found by immunoelectrophoresis that the prostatic PMEase which was in homogeneous form electrophoretically and ultracentrifugally, contained always siderophilin. Each PMEase fraction of the three peaks was examined on t h e enzymatic properties such as optimal pH., Michael's constant and inhibition test. The enzymatic properties of each PMEase fraction were slightly different each other.
- 泌尿器科紀要刊行会の論文
泌尿器科紀要刊行会 | 論文
- MVAC療法後の転移性尿路上皮癌に対するGemcitabine, Docetaxel, Carboplatin併用化学療法の検討
- Grade 3 Ta-1表在性膀胱癌に対する膀胱温存治療
- 腹腔鏡下に摘出した後腹膜神経線維腫の1例
- 移植腎生検による腎内動脈瘤破裂の1例
- Modified M-VAC療法後に残存腫瘍切除を施行した進行尿路上皮癌患者の治療成績